Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that members of its senior management team are scheduled to participate in the following upcoming virtual investor conferences:
Citi's 2022 Virtual Immuno-Oncology Summit
Event Date: February 16, 2022
SVB Leerink Virtual 11th Annual Global Healthcare Conference
Event Date: February 16, 2022
| Press Release in English | 140.69 KB |
| Communiqué en français | 145.63 KB |